Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China
Limits Duty-Free Treatment for Small Imports from China Linked to Opioids
What it does
Agencies must end duty-free de minimis treatment for eligible imports once the Commerce Secretary notifies the President that systems can collect the applicable tariffs.
Real-world impact
- Small shipments that were duty-free may lose that status once systems are ready.
- Importers of covered articles from China may face new tariff collection procedures.
- The Commerce Secretary must confirm systems to enable full tariff collection.
Topics
Summary
This order amends a prior order that imposed tariffs to address the synthetic opioid supply chain in the People’s Republic of China. It replaces a specific rule so that small, otherwise duty-free imports remain exempt only until the Commerce Secretary tells the President the government can reliably collect the new tariffs.
The change affects covered imports and the agencies that collect and report tariffs, and it aims to ensure tariff revenue on targeted articles can be fully and quickly collected.
Questions, answered
Ask questions about this executive order and its implications. Try:
- “What agencies are affected by this order?”
- “How does this order change existing policy?”
- “What are the practical implications of this order?”